U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.
<iframe src="https://statesidedaily.com/embed/cluster/d04476ce07453b182c2881cb33df7918d6814215" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA approves landmark pancreatic cancer drug that's shown to improve survival"></iframe>
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.
